Merck pursues new cancer combinations, prediction markets put pharma’s confidential information in focus and personalized ...
Oncology still accounts for nearly two out of five pipeline drugs, while obesity entered the top 10 indications and one-third ...
Manufacturing hurdles are just one challenge the industry must overcome to commercialize personalized mRNA cancer vaccines.
Plump joined Takeda during a turbulent period, pushed the company to work more closely with young biotechs and will leave it ...
The Alzheimer’s space has really got a fire under it,” says one analyst. But can the momentum deliver better drugs?
Success in women’s oncology isn’t just about buying patients more time but making those added months or years feel as close to normal as possible, according to Dr. Shweta Jain, vice president of ...
As betting expands into clinical trial outcomes, drugmakers may need to look beyond employees and scrutinize outside partners ...
After two notable failures, the social anxiety R&D space gained a major player when Eli Lilly agreed to acquire AtaiBeckley ...
After almost two years of turnover in the FDA’s top ranks, the new appointments should help ease concerns about more turmoil ahead, one analyst said.
Gilead’s new “Up to Date” campaign uses humor and dating scenarios to reach Black communities amid persistent gaps in HIV ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results